Latest & greatest articles for children

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on children or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on children and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for children

5701. Antidiarrheal agents in the treatment of acute diarrhea in children. (PubMed)

Antidiarrheal agents in the treatment of acute diarrhea in children. To evaluate the efficacy of antidiarrheal agents in the treatment of diarrheal illnesses, a study was conducted with children in Guatemala who had an acute diarrheal illness. Eighty patients, aged 3 to 11 years, were hospitalized and treated for two days with one of five agents: kaolin-pectin suspension concentrate (Kao-Con), kaolin suspension, pectin suspension, diphenoxylate-atropine liquid (Lomotil), or placebo. Although (...) the patients receiving kaolin-pectin produced stools that tended to be more formed than those of the placebo-treated group patients, the study did not demonstrate any effect by any of the agents tested in influencing the frequency of bowel movement, the water content of the stools, or the weight of stools. Kaolin-pectin suspension and diphenoxylate-atropine liquid do not appear to be useful in the relief of acute nonspecific diarrhea in children.

1976 JAMA

5702. Vitamin C and acute illness in Navajo school children. (PubMed)

Vitamin C and acute illness in Navajo school children. To evaluate earlier observations, including our own, showing usefulness of vitamin C for managing the common cold, we performed a double-blind trial of vitamin C versus placebo in 868 children. There was no difference in number becoming ill (133 versus 129), number of episodes (166 versus 159) or mean illness duration (5.5 versus 5.8 days) between the groups. Children receiving vitamin C had fewer throat cultures yielding beta-hemolytic (...) streptococcus (six versus 13, P less than 0.10), but no difference in overall complicated illness rate (24 versus 25). Plasma ascorbic acid levels were higher in the vitamin group 24 to 26 hours after supplementation (1.28 versus 1.04 mg per 100 ml, P less than 0.01). Children with high plasma ascorbic acid concentrations had longer mean illness (6.8 versus 4.0 days, P less than 0.05) than those with low levels. Vitamin C does not seem to be an effective prophylactic or therapeutic agent for upper

1976 NEJM

5703. Therapy with parent's lymphocyte transfer factor in children with infection and malnutrition. (PubMed)

Therapy with parent's lymphocyte transfer factor in children with infection and malnutrition. Transfer factor (T.F.) prepared from 5 x 10(8) lymphoid cells from 500 ml of a parent's blood was given to 40 Australian aboriginal children aged 2-46 months who had been in hospital with acute infection. Many had protein-calorie malnutrition. These and a control group of 35 similar children were assessed blind for at least 12 months. In T.F.-treated children there were significantly fewer episodes

1976 Lancet

5704. Long-term metaproterenol therapy in asthmatic children. (PubMed)

Long-term metaproterenol therapy in asthmatic children. The bronchodilator efficacy and safety of metaproterenol sulfate were evaluated by double-blind crossover tests against placebo at three intervals during a 90-day treatment period in 50 asthmatic children. One group of 25 patients was continuously treated with metaproterenol syrup, and the other 25 with placebo syrup. Pulmonary function tests showed statistically significant improvements in forced expiratory volume, forced expiratory

1976 JAMA

5705. Levamisole in prevention of recurrent upper-respiratory-tract infections in children. (PubMed)

Levamisole in prevention of recurrent upper-respiratory-tract infections in children. 70 children with chronically relapsing mild-to-severe upper-respiratory-tract infections during autumn and winter participated in a six month double-blind placebo-controlled trial: 38 of them received about 1-25 mg/kg of levamisole twice daily for two consecutive days every week, the others were given placebo. During each of the three trial periods, levamisole proved superior to placebo

1976 Lancet

5706. Effects of central-nervous-system irradiation on neuropsychologic functioning of children with acute lymphocytic leukemia. (PubMed)

Effects of central-nervous-system irradiation on neuropsychologic functioning of children with acute lymphocytic leukemia. Two neuropsychologic studies were performed to determine the long-term effects of "prophylactic" cranial or craniospinal irradiation on the psychologic and neurologic functions of children with acute lymphocytic leukemia. In a prospective study, 34 patients with leukemia who received either craniospinal irradiation or cranial irradiation combined with intrathecal

1975 NEJM

5707. Termination of restricted diet in children with phenylketonuria: a randomized controlled study. (PubMed)

Termination of restricted diet in children with phenylketonuria: a randomized controlled study. This study demonstrates the feasibility of a randomized controlled investigation of terminating the phenylalanine-restricted diet in four-year-old children with phenylketonuria. The parents of 14 of 16 children gave informed consent, knowing their children would be randomly assigned to either a diet-continuation or a diet-termination group. Compared with the continuation group, the mean serum (...) . Children in both groups showed some subtest scatter in memory and concentration. Thus, no harmful effects of diet termination were noted, but a longer period of observation in a larger number of subjects is needed.

1975 NEJM

5708. Acute lymphocytic leukemia in children: maintenance therapy with methotrexat administered intermittently. Acute Leukemia Group B. (PubMed)

Acute lymphocytic leukemia in children: maintenance therapy with methotrexat administered intermittently. Acute Leukemia Group B. 4303512 1969 03 21 2016 10 17 0098-7484 207 5 1969 Feb 03 JAMA JAMA Acute lymphocytic leukemia in children: maintenance therapy with methotrexat administered intermittently. Acute Leukemia Group B. 923-8 eng Clinical Trial Journal Article Randomized Controlled Trial United States JAMA 7501160 0098-7484 0 Hemoglobins 5J49Q6B70F Vincristine 9PHQ9Y1OLM Prednisolone

1969 JAMA

5709. Intracutaneous immune serum globulin therapy in allergic children. (PubMed)

Intracutaneous immune serum globulin therapy in allergic children. 4179194 1969 03 21 2016 10 17 0098-7484 207 5 1969 Feb 03 JAMA JAMA Intracutaneous immune serum globulin therapy in allergic children. 902-6 Hilman B C BC Triplett R F RF Crawford L V LV Kittler F J FJ Mattson D H DH eng Clinical Trial Journal Article Randomized Controlled Trial United States JAMA 7501160 0098-7484 0 Anti-Bacterial Agents 0 Bronchodilator Agents 0 Isoantibodies 0 Placebos 0 Steroids 0 gamma-Globulins YKH834O4BH

1969 JAMA

5710. Effectiveness of hyposensitization therapy in ragweed hay-fever in children. (PubMed)

Effectiveness of hyposensitization therapy in ragweed hay-fever in children. 5952104 1966 06 16 2016 10 17 0098-7484 195 12 1966 Mar 21 JAMA JAMA Effectiveness of hyposensitization therapy in ragweed hay-fever in children. 985-92 Fontana V J VJ Holt L E LE Jr Mainland D D eng Clinical Trial Comparative Study Journal Article Randomized Controlled Trial United States JAMA 7501160 0098-7484 0 Placebos AIM IM Adolescent Child Desensitization, Immunologic Humans Placebos Rhinitis, Allergic, Seasonal

1966 JAMA